官方服务：
资源简介：
RNA-seq results of melanoma tissue after HLJD treatment and HLJD+ICIs treatment
应用场景：
创建时间：
2022-04-09
相关数据集
total RNA-seq from macrophage (ENCSR272OBW)
Ribo depletion RNA-seq on cytoplasmic fraction RNA which is part of BMDM cell pre-treated with 100 ng/ml Lipid A 12 hours, washed out for 12 hours, and stimulated with 100 ng/ml Lipid A for 75 minute.
NIAID Data Ecosystem60
The PPAR agonist Rosiglitazone induces paracrine signaling in melanoma cells that activate stromal cells and enhances tumor growth.. The PPAR agonist Rosiglitazone induces paracrine signaling in melanoma cells that activate stromal cells and enhances tumor growth.
Besides improving insulin sensitivity in type 2 diabetes, the thiazolidinedione family of compounds and the pharmacologic activation of their best characterized target PPARg has been proposed as a the
NIAID Data Ecosystem50
A novel Chalcone derivative has antitumor activity in melanoma by inducing DNA damage through the upregulation of ROS products
Melanoma is one of the most aggressive tumors with the remarkable characteristic of resistance to traditional chemotherapy and radiotherapy. Although targeted therapy and immunotherapy benefit advance
NIAID Data Ecosystem20
Hs 294T Cells Treated with Elesclomol Alone or in Combination with NAC Compared to DMSO Treated
We used microarrays to detail gene expression changes in Hs 294T human melanoma cells after treatment with elesclomol alone, or in combination with NAC, to aide in identifing the mechnism of action of
NIAID Data Ecosystem60
Effect of alisertib and navitoclax on gene expression in B16 melanoma tumors. Effect of alisertib and navitoclax on gene expression in B16 melanoma tumors
To investigate how tumor cells respond to alisertib and navitoclax single agents and combonation therapy in vivo, mice with melanoma were treated with these agents or vehicle-contol. RNAseq was used t
NIAID Data Ecosystem30
